FDA Warning Letter — B & B Pharmaceuticals, Inc.

Case 570613 — FEI 3000719772

The FDA took a Warning Letter action against B & B Pharmaceuticals, Inc. on June 4, 2019 (Englewood, CO). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.

Action Details

Facility
B & B Pharmaceuticals, Inc.
Date
June 4, 2019
Fiscal Year
2019
Product Type
Drugs
Center
CDER
Location
Englewood, CO (United States)